Clincosm LogoSign in Get a demo

Breast Adenocarcinoma

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7 Trial in Worldwide (drug, other, radiation)

Active, not recruiting
Has Results
  • Breast Adenocarcinoma
  • +6 more
  • Anniston, Alabama
  • +1230 more
Jan 28, 2023

HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,

Completed
  • HER2-positive Breast Cancer
  • +8 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +6 more
  • Biopsy
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 6, 2023

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial

Withdrawn
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +28 more
  • Carbon Dioxide Fractional Laser
  • Questionnaire Administration
  • (no location specified)
Jan 5, 2023

Breast Adenocarcinoma, Invasive Breast Carcinoma, Resectable Breast Carcinoma Trial in Jacksonville (Biospecimen Collection,

Recruiting
  • Breast Adenocarcinoma
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Gut Microbiome and Chemotherapy-Induced Nausea in Women

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • Questionnaire Administration
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 4, 2023

Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma Trial in Richmond, South Hill (External Beam Radiation

Active, not recruiting
  • Breast Cancer
  • +4 more
  • External Beam Radiation Therapy
  • +2 more
  • Richmond, Virginia
  • +1 more
Dec 16, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +23 more
  • Quality-of-Life Assessment
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Nov 9, 2022

Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States

Recruiting
  • Breast Adenocarcinoma
  • +7 more
  • Multi-epitope HER2 Peptide Vaccine TPIV100
  • +5 more
  • Scottsdale, Arizona
  • +26 more
Aug 17, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)

Recruiting
  • Advanced Solid Tumor
  • +18 more
  • PT199
  • Anti-PD-1 monoclonal antibody
  • Huntersville, North Carolina
  • +2 more
Aug 10, 2022

Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)

Active, not recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Duarte, California
  • +4 more
Jul 16, 2022

Breast Tumors, Breast Cancer, Estrogen-receptor Positive Breast Cancer Trial in France, United Kingdom, United States (H3B-6545)

Active, not recruiting
  • Breast Neoplasms
  • +7 more
  • Goodyear, Arizona
  • +38 more
Jun 29, 2022

MRI Scans in People Who Have Breast Tissue Expanders After

Recruiting
  • Breast Cancer
  • +2 more
  • MRI Studies
  • Patient Reported Outcomes
  • Montvale, New Jersey
  • +2 more
May 31, 2022

Breast Adenocarcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Eribulin Mesylate, Laboratory

Suspended
  • Breast Adenocarcinoma
  • +4 more
  • Eribulin Mesylate
  • +3 more
  • Scottsdale, Arizona
  • +38 more
May 25, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +22 more
  • Microbiota-based Formulation RBX7455
  • Jacksonville, Florida
    Mayo Clinic in Florida
May 12, 2022

Breast Adenocarcinoma, Estrogen Receptor Negative, HER2/Neu Negative Trial in Canada, United States (Carboplatin,

Recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Mobile, Alabama
  • +1295 more
May 2, 2022

Breast Cancer, Breast Cancer Female, Breast Adenocarcinoma Trial in Tampa (Standard of Care Schedule Variation: SABR,

Terminated
Has Results
  • Breast Cancer
  • +2 more
  • Standard of Care Schedule Variation: SABR
  • Breast-conserving Surgery
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Apr 26, 2022

Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma Trial in Canada,

Recruiting
  • Breast Adenocarcinoma
  • +8 more
  • Birmingham, Alabama
  • +667 more
Apr 6, 2022

Breast Cancer, Breast Adenocarcinoma, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Bronx (Rebastinib,

Terminated
  • Breast Cancer
  • +4 more
  • Bronx, New York
    Montefiore Medical Center
Mar 23, 2022

HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer Trial in Duarte, Lancaster, South Pasadena

Active, not recruiting
  • HER2-positive Breast Cancer
  • +9 more
  • pertuzumab
  • +3 more
  • Duarte, California
  • +2 more
Mar 17, 2022

Breast Adenocarcinoma, Metastatic Triple-Negative Breast Carcinoma, Stage III Breast Cancer AJCC v7 Trial in Jacksonville (drug,

Active, not recruiting
  • Breast Adenocarcinoma
  • +6 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Dec 14, 2021

Breast Adenocarcinoma, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Houston (Accelerated Partial Breast

Recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Accelerated Partial Breast Irradiation
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 21, 2021

Breast Adenocarcinoma, HER2/Neu Negative, Locally Advanced Breast Carcinoma Trial in South Africa, United States (Entinostat,

Active, not recruiting
Has Results
  • Breast Adenocarcinoma
  • +9 more
  • Birmingham, Alabama
  • +662 more
Oct 18, 2021

Anti-HER2 Therapies in HER2-Positive Stage I-IV Breast Cancer

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +23 more
  • Biospecimen Collection
  • Jacksonville, Florida
    Mayo Clinic in Florida
Aug 9, 2021